TY - JOUR
T1 - Correction
T2 - The antioxidant and antimicrobial activity of ethanolic extract in roots, stems, and leaves of three commercial Cymbopogon species (BMC Complementary Medicine and Therapies, (2024), 24, 1, (272), 10.1186/s12906-024-04573-4)
AU - Wahyuni, Dwi Kusuma
AU - Kharisma, Viol Dhea
AU - Murtadlo, Ahmad Affan Ali
AU - Rahmawati, Cici Tya
AU - Syukriya, Alvi Jauharotus
AU - Prasongsuk, Sehanat
AU - Subramaniam, Sreeramanan
AU - Wibowo, Anjar Tri
AU - Purnobasuki, Hery
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - Correction: BMC Complement Med Ther 24, 272 (2024) Following publication of the original article [1], the authors identified an error in Fig. 1. The correct figure is given below. GC–MS chromatogram of Cymbopogon spp. ethanolic extract. A Roots, B stems, C leaves. (I) Cymbopogon citratus, (II) Cymbopogon nardus, III Cymbopogon winterianus. (a) Tetraethyl silicate; (b) Geraniol; (c) Methyleugenol; (d) Benzene, 1,2-dimethoxy-4-(1-propenyl)-; (e) Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-7-methyl-4-methylene-1-(1-methylethyl)-, (1.alpha.,4a.beta.,8a.alpha.)-; f. gamma.-Muurolene; g. Phenol, 2,5-bis(1,1-dimethylethyl); h. Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1 S-cis)-; i. tau.-Muurolol; j. (1 S,4aS,7R,8aS)-1,4a-Dimethyl-7-(prop-1-en-2-yl) decahydronaphthalen-1-ol; k. 1-((1 S,3aR,4R,7 S,7aS)-4-Hydroxy-7-isopropyl-4-methyloctahydro-1 H-inden-1-yl) ethanone; l. Benzenepropanoic acid, 3,5-bis (1,1-dimethylethyl)-4-hydroxy-, methyl ester; m. Phytol. Green arrow: Selin-6-en-4.alpha.-ol; yellow arrow: alpha.-Cadinol; black arrow: Hexadecanoic acid, methyl ester The original article has been corrected.
AB - Correction: BMC Complement Med Ther 24, 272 (2024) Following publication of the original article [1], the authors identified an error in Fig. 1. The correct figure is given below. GC–MS chromatogram of Cymbopogon spp. ethanolic extract. A Roots, B stems, C leaves. (I) Cymbopogon citratus, (II) Cymbopogon nardus, III Cymbopogon winterianus. (a) Tetraethyl silicate; (b) Geraniol; (c) Methyleugenol; (d) Benzene, 1,2-dimethoxy-4-(1-propenyl)-; (e) Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-7-methyl-4-methylene-1-(1-methylethyl)-, (1.alpha.,4a.beta.,8a.alpha.)-; f. gamma.-Muurolene; g. Phenol, 2,5-bis(1,1-dimethylethyl); h. Naphthalene, 1,2,3,5,6,8a-hexahydro-4,7-dimethyl-1-(1-methylethyl)-, (1 S-cis)-; i. tau.-Muurolol; j. (1 S,4aS,7R,8aS)-1,4a-Dimethyl-7-(prop-1-en-2-yl) decahydronaphthalen-1-ol; k. 1-((1 S,3aR,4R,7 S,7aS)-4-Hydroxy-7-isopropyl-4-methyloctahydro-1 H-inden-1-yl) ethanone; l. Benzenepropanoic acid, 3,5-bis (1,1-dimethylethyl)-4-hydroxy-, methyl ester; m. Phytol. Green arrow: Selin-6-en-4.alpha.-ol; yellow arrow: alpha.-Cadinol; black arrow: Hexadecanoic acid, methyl ester The original article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85201417191&partnerID=8YFLogxK
U2 - 10.1186/s12906-024-04599-8
DO - 10.1186/s12906-024-04599-8
M3 - Comment/debate
C2 - 39143559
AN - SCOPUS:85201417191
SN - 1472-6882
VL - 24
JO - BMC Complementary Medicine and Therapies
JF - BMC Complementary Medicine and Therapies
IS - 1
M1 - 307
ER -